VKTX
VKTX
NASDAQ · Biotechnology

Viking Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$32.17
-0.38 (-1.17%)
As of Mar 24, 10:00 PM ET ·
Analyst Consensus
Strong Buy
24
Analysts
High
Coverage
Buy 22 92%
Hold 2 8%
Sell 0 0%
Price Target
Analyst Price Target +112.0% upside
Low Target $46.84
Average Target $68.21
High Target $80.11
Current Price $32.17
Current
$32.17
Target
$68.21
$46.84 $68.21 avg $80.11
Scenario Analysis
Bear Case
$46.84
45.6%
Low target
Base Case
$68.21
+112.0%
Avg target
Bull Case
$80.11
+149.0%
High target
Risk/Reward
3.3x
Highly favorable
Price in Context
52-Week High
$43.15
-25.4% from high
52-Week Low
$18.92
+70.0% from low
50-Day SMA
$32.83
-2.0% vs SMA
200-Day SMA
$31.34
+2.6% vs SMA
RSI (14)
52.7
Neutral
Target vs 52W High
$68.21
+58.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -26.5%